Catalyst Wire Dossier Catalyst Wire Dossier

IgT cells

Immunogene-modified T cells · Shenzhen Geno-Immune Medical Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IgT cells, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme [Phase 1]

See pricing